The CXCR3alt-CXCL11 axis in bladder cancer: potential for prediction of neoadjuvant chemotherapy response
Stephen Chenard1,2, D Robert Siemens1,2,3, Madhuri Koti4,5,6
1Queen's Cancer Research Institute, Kingston, ON, Canada.
Cellular & Molecular Immunology
|May 15, 2021
Abstract
No abstract available in PubMed .


